The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

PD-1 trial stopped early

vinnyc
vinnyc CSN Member Posts: 19
edited January 2015 in Kidney Cancer #1

http://news.bms.com/press-release/checkmate-017-phase-3-study-opdivo-nivolumab-compared-docetaxel-patients-second-line-s

Superior preliminary data for ns lung ca. FDA should approve soon. Renal cell cancer trial preliminary data PD-1 Opdivo vs Affinitor Everolimus should come summer 2015, hopefully and hopefully will be superior and quickly FDA approved. 

 

http://www.marketwatch.com/story/checkmate--017-a-phase-3-study-of-opdivo-nivolumab-compared-to-docetaxel-in-patients-with-second-line-squamous-cell-non-small-cell-lung-cancer-stopped-early-2015-01-11

Like Care

Comments

  • angec
    angec CSN Member Posts: 924 Member
    #2
    Thanks for the info.. let's

    Thanks for the info.. let's hope it works out that way!

    Like Care

Discussion Boards